PCR Quantification Using Michaelis-Menten Kinetics

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional quantitative PCR methods face challenges in accurately determining the initial concentration of target nucleic acids due to assumptions about PCR efficiency, which can vary between samples and experiments, leading to uncertainties in comparing different samples and genes.

Innovation Solution

The approach involves fitting PCR amplification curves to the Michaelis-Menten kinetics model, allowing direct estimation of the initial template DNA concentration and effective Michaelis-Menten constant without requiring efficiency information, using amplification curve points from both exponential and linear phases, and requiring only one calibration point.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional qPCR methods are used to determine initial nucleic acid concentration, then quantification can be performed, but uncertainties arise due to variable PCR efficiency assumptions

Engineering Contradiction:
Improveaccuracy of initial nucleic acid concentration determinationVSAvoidconsistency of PCR efficiency assumptions
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The invention changes the mathematical model parameters from exponential growth (Nn = N0 × (1+E)^n) to Michaelis-Menten kinetics (Nn = N0 × (1 + K/(K+Nn-1))). This parameter transformation eliminates the need to assume constant PCR efficiency E, as the Michaelis-Menten model inherently accounts for efficiency variations through the constant K, thereby resolving the reliability issue while maintaining measurement precision

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention substitutes the conventional exponential growth model with a biochemical kinetics model (Michaelis-Menten). This replacement is appropriate because PCR is fundamentally an enzymatic reaction governed by Michaelis-Menten kinetics, and using the biologically accurate model eliminates the need for efficiency assumptions, thus improving both reliability and precision

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Ease of manufacture

If PCR efficiency is assumed constant for quantification, then calculations are simplified, but accuracy decreases when efficiency varies between samples

Engineering Contradiction:
Improvesimplicity of quantification calculationVSAvoidaccuracy of nucleic acid ratio comparison
Core Design Contradiction:
Ease of manufactureVSMeasurement precision

Solution Approach 1:

The Michaelis-Menten model serves multiple functions simultaneously: it simplifies calculations by using a single constant K that applies universally across all samples and genes, while also accurately capturing efficiency variations. This universal constant replaces the sample-specific efficiency assumptions, achieving both computational simplicity and measurement accuracy

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The Michaelis-Menten model is self-sufficient and does not require external efficiency information or calibration curves for each sample. The constant K inherently accounts for all efficiency factors, making the quantification method independent of sample-specific variations and eliminating the need for complex efficiency measurements

Inventive Principle:
Principle #25Self-service

3Measurement precision

If multiple calibration points are used in standard qPCR, then efficiency can be determined, but the process becomes more complex and time-consuming

Engineering Contradiction:
Improveefficiency determination accuracyVSAvoidnumber of calibration points required
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The invention extracts and isolates the essential kinetic parameter K from the complex efficiency determination process. By focusing on this single constant that captures the essential behavior of PCR kinetics, the method eliminates the need for multiple calibration points and complex efficiency calculations, reducing procedural complexity while maintaining precision

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The Michaelis-Menten model with constant K is established as a preliminary framework that inherently accounts for efficiency characteristics. This pre-established model eliminates the need for subsequent efficiency determination steps using multiple calibration points, streamlining the overall process while preserving measurement accuracy

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method reduces uncertainties related to PCR efficiency, minimizing the coefficient of variation of the initial nucleic acid ratio by up to 10-fold compared to standard qPCR, providing more accurate and reliable quantification of initial nucleic acid concentrations.

Implementation Method 1

The polymerase chain reaction (PCR) is an in vitro method for enzymatically synthesizing or amplifying defined nucleic acid sequences

Methodology Applied
Scientific EffectPolymerase chain reaction (PCR):

Implementation Method 2

Elongation of the primers is catalyzed by a heat-stable DNA polymerase

Methodology Applied
Scientific EffectEnzymatic synthesis: Enzyme

Implementation Method 3

Fluorescent probes or markers are typically used in real-time PCR, or kinetic PCR, to facilitate detection and quantification of the amplification process

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentUS8386184B2Systems and methods for determining an amount of starting reagent using the polymerase chain reaction
Publication Date: 2013.02.26 BECTON DICKINSON & CO
  • US8386184B2 patent drawing
  • US8386184B2 patent drawing
  • US8386184B2 patent drawing

AI summary

Systems and methods for calculating an initial amount of target nucleic acid N0 in a sample are provided. A plurality of fluorescent measurements is received. Each respective fluorescent measurement FSn is taken in a different cycle n in a PCR amplification experiment of the sample. Then, a model for the PCR amplification experiment is computed. For each respective fluorescent measurement, the model comprises a respective equation for Nn, where (i) Nn is the calculated amount of the target nucleic acid in cycle n of the corresponding PCR amplification experiment, and (ii) the equation for Nn is expressed in terms of K and N0, where K is the Michaelis-Menton constant. The model can be refined by adjusting K and N0 until differences between model values Nn and corresponding fluorescent measurements are minimized, thereby calculating the initial amount of a target nucleic acid N0 as the minimized value for N0 for the model.